For pharmaceuticals, much of the initial research is conducted by the pharmaceutical industry, guided by basic science but also delimited by potential markets, regulatory approval requirements, trial size considerations, and payer expectations for evidence of value.
We therefore set out to elucidate the coverage of the four domains Uniform Requirements, trial registration, conflicts of interest and reporting guidelines in Open Access pediatric journals.
We analyzed to what extent author instructions of Open Access pediatric journals reflect recommendations on four domains of editorial policy: Uniform Requirements, trial registration, conflicts of interest and reporting guidelines.
BL was involved in the implementation of trial-specific requirements for trial medication and virological aspects and reviewed the manuscript.
Overall, no consistent clinically important differences were observed for diarrhoea duration, stool volume, or hydration requirements (three trials, 230 participants, Analysis 8.1; Analysis 8.2,Analysis 8.4), or for duration of pathogen excretion (two trials, 66 participants, Analysis 8.5).
We analyzed the requirements of trials in this environment, and constructed an information model to drive development of systems supporting trial design, execution, and analysis.
Therefore, they do not fulfill scientific requirements for trials on new drugs.
They described criteria based on absolute sample size as unsupportable due to differing design requirements across trials.
It is developed to satisfy the requirements of trials that need complex processing that cannot be handled by MIRC.
These activities include structured interoperability among participants, standard operating procedures to be adopted, to adhere to GCP and the requirements of trials included in the applications for MA, ethical, administrative and contractual requirements, etc.
